J. Qin, R. Li, J. Raes, M. Arumugam, K. S. Burgdorf et al., A human gut microbial gene catalog established by metagenomic sequencing, Nature. 4 mars, vol.464, issue.7285, pp.59-65, 2010.

C. Landman and E. Quévrain, Le microbiote intestinal: description, rôle et implication physiopathologique, Rev Med Interne. juin, vol.37, issue.6, pp.418-441, 2016.

I. Cho and M. J. Blaser, The human microbiome: at the interface of health and disease, Nat Rev Genet. 13 mars, vol.13, issue.4, pp.260-70, 2012.

S. M. Jandhyala, Role of the normal gut microbiota, World Journal of Gastroenterology, vol.21, issue.29, p.8787, 2015.

G. Frost, M. L. Sleeth, M. Sahuri-arisoylu, B. Lizarbe, S. Cerdan et al., The shortchain fatty acid acetate reduces appetite via a central homeostatic mechanism, Nat Commun. 29 avr, vol.5, p.3611, 2014.

C. Milani, S. Duranti, F. Bottacini, E. Casey, F. Turroni et al., The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota, Microbiol Mol Biol Rev, vol.81, issue.4, 2017.

L. Houézec, D. Nicolle, and M. , Quid du microbiote en pédiatrie ? Médecine & enfance, vol.38, pp.265-71, 2018.

M. J. Butel and J. Aires, Quid du microbiote en pédiatrie ? (suite). Médecine & enfance. mars

S. Y. Huh, S. L. Rifas-shiman, C. A. Zera, J. Edwards, E. Oken et al., Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study, Arch Dis Child. juill, vol.97, issue.7, pp.610-616, 2012.

B. Laubereau, B. Filipiak-pittroff, V. Berg, A. Grubl, A. Reinhardt et al., Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life, Arch Dis Child, vol.89, issue.11, pp.993-1000, 2004.

T. Gill, M. Asquith, J. T. Rosenbaum, and R. A. Colbert, The Intestinal Microbiome in

. Spondyloarthritis, Curr Opin Rheumatol. juill, vol.27, issue.4, pp.319-344, 2015.

K. Mårild, O. Stephansson, S. Montgomery, J. A. Murray, and J. F. Ludvigsson, Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study

, Gastroenterology. janv, vol.142, issue.1, pp.39-45, 2012.

M. F. Zurita, P. A. Cárdenas, M. E. Sandoval, M. C. Peña, M. Fornasini et al.,

, Analysis of gut microbiome, nutrition and immune status in autism spectrum disorder: a casecontrol study in Ecuador. Gut Microbes, pp.1-12, 2019.

C. R. Cardwell, L. C. Stene, G. Joner, O. Cinek, J. Svensson et al., Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a metaanalysis of observational studies, Diabetologia. mai, vol.51, issue.5, pp.726-761, 2008.

N. Grall, A. Andremont, and E. Ruppé, Microbiote intestinal. Biologie médicale, vol.12, 2017.

A. S. Kalakuntla, G. Nalakonda, K. Nalakonda, C. V. Pidikiti, and S. A. Aasim, Probiotics and Clostridium Difficile: A Review of Dysbiosis and the Rehabilitation of Gut Microbiota, Cureus. 2 juill, vol.11, issue.7, p.5063, 2019.

Y. Bhattarai, D. A. Muniz-pedrogo, and P. C. Kashyap, Irritable bowel syndrome: a gut microbiota-related disorder?, Am J Physiol Gastrointest Liver Physiol, vol.01, issue.1, pp.52-62, 2017.

H. Raskov, J. Burcharth, H. Pommergaard, and J. Rosenberg, Irritable bowel syndrome, the microbiota and the gut-brain axis, Gut Microbes, vol.02, issue.5, pp.365-83, 2016.

R. Balamurugan, H. P. Janardhan, S. George, M. V. Raghava, J. Muliyil et al.,

, Molecular Studies of Fecal Anaerobic Commensal Bacteria in Acute Diarrhea in Children, Journal of Pediatric Gastroenterology and Nutrition. mai, vol.46, issue.5, pp.514-523, 2008.

C. Ma, X. Wu, M. Nawaz, J. Li, P. Yu et al., Molecular characterization of fecal microbiota in patients with viral diarrhea, Curr Microbiol. sept, vol.63, issue.3, pp.259-66, 2011.

F. Savino, F. Cresi, S. Pautasso, E. Palumeri, V. Tullio et al., Intestinal microflora in breastfed colicky and non-colicky infants, Acta Paediatr. juin, vol.93, issue.6, pp.825-834, 2004.

F. Savino, L. Cordisco, V. Tarasco, R. Calabrese, E. Palumeri et al., Molecular identification of coliform bacteria from colicky breastfed infants, Acta Paediatr, vol.98, issue.10, pp.1582-1590, 2009.

J. Zeevenhooven, P. D. Browne, L. 'hoir, M. P. De-weerth, C. Benninga et al., Infant colic: mechanisms and management, Nat Rev Gastroenterol Hepatol, vol.15, issue.8, pp.479-96, 2018.

N. E. Dubois and K. E. Gregory, Characterizing the Intestinal Microbiome in Infantile Colic: Findings Based on an Integrative Review of the Literature, Biol Res Nurs. mai, vol.18, issue.3, pp.307-322, 2016.

H. Eutamène, C. L. Garcia-rodenas, S. Yvon, E. Aldebert, F. Foata et al.,

, Luminal contents from the gut of colicky infants induce visceral hypersensitivity in mice

&. Neurogastroenterology and . Motility, , vol.29, p.12994, 2017.

S. Bibbò, G. Ianiro, V. Giorgio, F. Scaldaferri, L. Masucci et al., The role of diet on gut microbiota composition, Eur Rev Med Pharmacol Sci, vol.20, issue.22, pp.4742-4751, 2016.

. Fao/oms, Consultation mixte d'experts FAO/OMS sur l'évaluation des propriétés sanitaires et nutritionnelles des probiotiques dans les aliments

A. Cordoba, , 2001.

B. C. Chapman, H. B. Moore, D. M. Overbey, A. P. Morton, B. Harnke et al., Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review, J Trauma Acute Care Surg, vol.81, issue.4, pp.756-64, 2016.

S. Paramsothy, R. Paramsothy, D. T. Rubin, M. A. Kamm, N. O. Kaakoush et al.,

, Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis, J Crohns Colitis, vol.11, issue.10, pp.1180-99, 2017.

D. L. Suskind, M. J. Brittnacher, G. Wahbeh, M. L. Shaffer, H. S. Hayden et al., Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn's disease, Inflamm Bowel Dis. mars, vol.21, issue.3, pp.556-63, 2015.

C. Wegh, S. Y. Geerlings, J. Knol, G. Roeselers, and C. Belzer, Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond, International Journal of Molecular Sciences. janv, vol.20, p.4673, 2019.

F. Guarner, M. E. Sanders, R. Eliakim, R. Fedorak, A. Gangl et al.,

, Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics, 2017.

J. Suez, N. Zmora, E. Segal, and E. Elinav, The pros, cons, and many unknowns of probiotics

, Nat Med, vol.25, issue.5, pp.716-745, 2019.

N. Zmora, G. Zilberman-schapira, J. Suez, U. Mor, M. Dori-bachash et al.,

, Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features, Cell. 6 sept, vol.174, issue.6, pp.1388-1405, 2018.

P. Marteau, Safety aspects of probiotic products. Food & Nutrition Research. 1 déc

. Fao/oms, Guidelines for the Evaluation of Probiotics in Food, 2002.

D. Sur, Saccharomyces boulardii (ultra-levure) : ajout d'une contre-indication chez les patients en état critique ou immunodéprimés -Lettres aux professionnels de santé

I. Hojsak, V. Fabiano, T. L. Pop, O. Goulet, G. V. Zuccotti et al., Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups, Acta Paediatr. juin, vol.107, issue.6, pp.927-964, 2018.

H. Szajewska, R. B. Canani, A. Guarino, I. Hojsak, F. Indrio et al., Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children, Journal of Pediatric Gastroenterology and Nutrition. mars, vol.62, issue.3, 2016.

A. Horvath, P. Dziechciarz, and H. Szajewska, Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood, Aliment Pharmacol Ther. juin, vol.33, issue.12, pp.1302-1312, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00633997

C. Romano, &. Ferrau, F. Cavataio, G. Iacono, M. Spina et al., Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health, vol.50, pp.68-71, 2014.

Z. Weizman, J. Abu-abed, and M. Binsztok, Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial, J Pediatr, vol.174, pp.160-164, 2016.

O. Jadresin, I. Hojsak, Z. Misak, A. J. Kekez, T. Trbojevic et al., Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study, J Pediatr Gastroenterol Nutr, vol.64, issue.6, pp.925-934, 2017.

H. Szajewska, A. Skórka, M. Ruszczy?ski, D. Gieruszczak-bia?ek, and . Meta-analysis,

, Lactobacillus GG for treating acute gastroenteritis in children -updated analysis of randomised controlled trials, Alimentary Pharmacology & Therapeutics. sept, vol.38, issue.5, pp.467-76, 2013.

E. C. Dinleyici, M. Eren, M. Ozen, Z. A. Yargic, and Y. Vandenplas, Effectiveness and safety of

, Saccharomyces boulardii for acute infectious diarrhea, Expert Opinion on Biological Therapy. avr, vol.12, issue.4, pp.395-410, 2012.

F. Indrio, D. Mauro, A. Riezzo, G. Civardi, E. Intini et al., Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial, JAMA Pediatr. mars, vol.168, issue.3, pp.228-261, 2014.

M. Urbanska and H. Szajewska, The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence, Eur J Pediatr, vol.173, issue.10, pp.1327-1364, 2014.

H. Szajewska, A. Guarino, I. Hojsak, F. Indrio, S. Kolacek et al., Use of Probiotics for Management of Acute Gastroenteritis: A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics, Journal of Pediatric Gastroenterology and Nutrition. avr, vol.58, issue.4, p.531, 2014.

, Liste officielle des médicaments déremboursés au 1er mars, HAS, 2006.

D. Sur,

C. Simone, The Unregulated Probiotic Market, Clin Gastroenterol Hepatol. avr, vol.17, issue.5, pp.809-826, 2019.

L. Edmunds, The underuse of probiotics by family physicians, CMAJ. 29 mai, vol.164, issue.11, p.1577, 2001.

A. Mesenburg, Probiotiques et prébiotiques : bases théoriques, utilisations et intérêts en médecine générale

M. Barbe, Utilisation des prébiotiques en médecine générale de ville

Z. Alonso, Analyse des pratiques sur la prescription de probiotiques chez l'enfant par les médecins généralistes de la communauté urbaine de Bordeaux

S. Jradi-hocine and . Probiotiques, évaluation des connaissances et pratiques d'une échantillon de médecins généralistes d'Ile-de-France : une étude qualitative à partir d'entretiens semi-directifs

, Université Paris XIII, 2017.

E. Courdier, Probiotiques : bases théoriques, opinions et pratiques des médecins généralistes

Z. Weizman, Probiotics use in childhood acute diarrhea: a web-based survey, J Clin Gastroenterol. juin, vol.45, issue.5, pp.426-434, 2011.

M. Laboratoires, Probiolog® DIA Enfant-Nourrisson

C. Chapman, G. R. Gibson, and I. Rowland, Health benefits of probiotics: are mixtures more effective than single strains?, Eur J Nutr. févr, vol.50, issue.1, pp.1-17, 2011.

Q. Guo, J. Z. Goldenberg, C. Humphrey, E. Dib, R. Johnston et al., Probiotics for the prevention of pediatric antibiotic-associated diarrhea, Cochrane Database Syst Rev. avr, issue.4, 2019.

H. Szajewska and M. Ko?odziej, Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults

, Alimentary Pharmacology & Therapeutics, vol.42, issue.10, pp.1149-57, 2015.

H. Szajewska and M. Ko?odziej, Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea, Alimentary Pharmacology & Therapeutics. oct, vol.42, issue.7, pp.793-801, 2015.

H. Szajewska and A. Skorka, Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials, Aliment Pharmacol Ther, vol.30, issue.9, pp.960-961, 2009.

T. G. Ong, M. Gordon, S. S. Banks, M. R. Thomas, and A. K. Akobeng, Probiotics to prevent infantile colic, Cochrane Database Syst Rev. mars, issue.3, 2019.

S. Cruchet, R. Furnes, A. Maruy, E. Hebel, J. Palacios et al., The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts, Paediatr Drugs. juin, vol.17, issue.3, pp.199-216, 2015.

D. Cameron, Q. S. Hock, M. Kadim, N. Mohan, E. Ryoo et al., Probiotics for gastrointestinal disorders: Proposed recommendations for children of the Asia-Pacific region

, World J Gastroenterol. 7 déc, vol.23, issue.45, pp.7952-64, 2017.

K. Lim, J. Jeong, S. Oh, Y. Moon, and J. Koh, Current Market Trends and Perspectives of

, ULTRA-LEVURE 100 mg pdre p susp buv en sachet, Probiotics. Current Topic in Lactic Acid Bacteria and Probiotics. févr, vol.3, issue.2, 2015.

T. Didari, S. Solki, S. Mozaffari, S. Nikfar, and M. Abdollahi, A systematic review of the safety of probiotics, Expert Opin Drug Saf. févr, vol.13, issue.2, pp.227-266, 2014.

L. Breton-lerouvillois and G. , La démographie médicale en région Aquitaine. Situation en, 2013.

D. Sur,

K. Draper, C. Ley, and J. Parsonnet, Probiotic guidelines and physician practice: a crosssectional survey and overview of the literature, Benef Microbes. 24 août, vol.8, issue.4, pp.507-526, 2017.

, Imgalt® (Jaldes) -5 souches de bifidobactéries et lactobacilles Lactéol® (Adare) -Lactobacillus fermentum, Lactobacillus delbrueckii Lactibiane® ATB (Pileje) -Lactobacillus rhamnosus

P. Spindler, Lactobacillus acidophilus, Bifidobacterium lactis Probiolog® enfant-nourrisson (Mayoly Spindler) Lactobacillus rhamnosus GG Smebiocta® (Ipsen) -Lactobacillus plantarum 299v

, Supraflor Arkobiotics® (Arkopharma) -6 souches de bifidobactéries et lactobacilles Symbiosys Alflorex® (Biocodex) -Bifidobacterium infantis Ultra levure® 50 mg (Biocodex) -Saccharomyces boulardii Ultra levure® 100 mg (Biocodex) -Saccharomyces boulardii Ultra levure® 200 mg (Biocodex) -Saccharomyces boulardii

. Ultra-baby®, Biocodex) -Saccharomyces boulardii Autre 16. Pour quelle durée en moyenne prescrivez-vous ces probiotiques ? *

, Concernant la prévention de la diarrhée associée aux antibiotiques (2/4)

*. , Une seule réponse possible) Je n'utilise pas de probiotiques (Passez à la question 22)

, Quelle dose journalière prescrivez-vous ? (Une seule réponse possible par ligne)

. Arkolevure®, Saccharomyces boulardii + inuline Baby-Flore® (Synergia) -Lactobacillus helveticus, Lactobacillus rhamnosus Babybiane Imedia (Pileje) -Lactobacillus rhamnosus GG Bacilor® (Alfa Wassermann) -Lactobacillus casei rhamnosus

, BioGaia® ProTectis (PediAct) -Lactobacillus reuteri

J. Bion®3-défense, Lactobacillus gasseri, Bifidobacterium bifidum, Bifidobacterium longum + Vitamines + Minéraux Ergyphilus Enfants (Nutergia) -Lactobacillus rhamnosus GG, Lactobacillus fermentum

, Imgalt® (Jaldes) -5 souches de bifidobactéries et lactobacilles

. Lactéol®, Lactobacillus fermentum, Lactobacillus delbrueckii Lactibiane® ATB (Pileje) -Lactobacillus rhamnosus

P. Spindler, Lactobacillus acidophilus, Bifidobacterium lactis Probiolog® enfant-nourrisson (Mayoly Spindler) Lactobacillus rhamnosus GG Smebiocta® (Ipsen) -Lactobacillus plantarum 299v

, Supraflor Arkobiotics® (Arkopharma) -6 souches de bifidobactéries et lactobacilles Symbiosys Alflorex® (Biocodex) -Bifidobacterium infantis

, Ultra levure® 50 mg (Biocodex) -Saccharomyces boulardii

, Ultra levure® 100 mg (Biocodex) -Saccharomyces boulardii

, Ultra levure® 200 mg (Biocodex) -Saccharomyces boulardii

. Ultra-baby®, Pour quelle durée en moyenne prescrivez-vous ces probiotiques ? *, Saccharomyces boulardii Autre 20

*. , Une seule réponse possible) Je n'utilise pas de probiotiques (Passez à la question 26)

, Quelle dose journalière prescrivez-vous ? (Une seule réponse possible par ligne)

. Arkolevure®, Saccharomyces boulardii + inuline Baby-Flore® (Synergia) -Lactobacillus helveticus, Lactobacillus rhamnosus Babybiane Imedia (Pileje) -Lactobacillus rhamnosus GG Bacilor® (Alfa Wassermann) -Lactobacillus casei rhamnosus

, BioGaia® ProTectis (PediAct) -Lactobacillus reuteri

J. Bion®3-défense, Lactobacillus gasseri, Bifidobacterium bifidum, Bifidobacterium longum + Vitamines + Minéraux Ergyphilus Enfants (Nutergia) -Lactobacillus rhamnosus GG, Lactobacillus fermentum

, Imgalt® (Jaldes) -5 souches de bifidobactéries et lactobacilles

. Lactéol®, Lactobacillus fermentum, Lactobacillus delbrueckii Lactibiane® ATB (Pileje) -Lactobacillus rhamnosus

P. Spindler, Lactobacillus acidophilus, Bifidobacterium lactis Probiolog® enfant-nourrisson (Mayoly Spindler) Lactobacillus rhamnosus GG Smebiocta® (Ipsen) -Lactobacillus plantarum 299v

, Supraflor Arkobiotics® (Arkopharma) -6 souches de bifidobactéries et lactobacilles Symbiosys Alflorex® (Biocodex) -Bifidobacterium infantis

, Ultra levure® 50 mg (Biocodex) -Saccharomyces boulardii

, Ultra levure® 100 mg (Biocodex) -Saccharomyces boulardii

, Ultra levure® 200 mg (Biocodex) -Saccharomyces boulardii

. Ultra-baby®, Pour quelle durée en moyenne prescrivez-vous ces probiotiques ? *, Biocodex) -Saccharomyces boulardii Autre, vol.24

*. , Une seule réponse possible) Je n'utilise pas de probiotiques (Passez à la question 30)

, Passez à la question 30) Il m'arrive de prescrire des probiotiques

, Quelle dose journalière prescrivez-vous ? (Une seule réponse possible par ligne)

. Arkolevure®, Saccharomyces boulardii + inuline Baby-Flore® (Synergia) -Lactobacillus helveticus, Lactobacillus rhamnosus Babybiane Imedia (Pileje) -Lactobacillus rhamnosus GG Bacilor® (Alfa Wassermann) -Lactobacillus casei rhamnosus

, BioGaia® ProTectis (PediAct) -Lactobacillus reuteri

J. Bion®3-défense, Lactobacillus gasseri, Bifidobacterium bifidum, Bifidobacterium longum + Vitamines + Minéraux Ergyphilus Enfants (Nutergia) -Lactobacillus rhamnosus GG, Lactobacillus fermentum

, Imgalt® (Jaldes) -5 souches de bifidobactéries et lactobacilles

. Lactéol®, Lactobacillus fermentum, Lactobacillus delbrueckii Lactibiane® ATB (Pileje) -Lactobacillus rhamnosus

P. Spindler, Lactobacillus acidophilus, Bifidobacterium lactis Probiolog® enfant-nourrisson (Mayoly Spindler) Lactobacillus rhamnosus GG Smebiocta® (Ipsen) -Lactobacillus plantarum 299v

, Supraflor Arkobiotics® (Arkopharma) -6 souches de bifidobactéries et lactobacilles Symbiosys Alflorex® (Biocodex) -Bifidobacterium infantis

, Ultra levure® 50 mg (Biocodex) -Saccharomyces boulardii

, Ultra levure® 100 mg (Biocodex) -Saccharomyces boulardii

, Ultra levure® 200 mg (Biocodex) -Saccharomyces boulardii

. Ultra-baby®, Biocodex) -Saccharomyces boulardii Autre 28. Pour quelle durée en moyenne prescrivez-vous ces probiotiques ? *